Ownership of Newly Created Intellectual Property. (a) All Intellectual Property developed solely by a Party or acquired from a third party by a Party during the Term, whether in connection with this Agreement or otherwise, (“Improvements”) will be owned solely by such Party.
Ownership of Newly Created Intellectual Property. (a) Each Party shall exclusively own all intellectual property (including, without limitation, Know-How, Patents and Patent Applications and copyrights) discovered, invented, authored or otherwise created solely by such Party, its employees, agents and consultants under the Discovery Program (“Sole Inventions”). Sole Inventions made solely by Sanofi, its employees, agents and consultants are referred to herein as “Sanofi Sole Inventions.” Sole Inventions made solely by Regeneron, its employees, agents and consultants are referred to herein as “Regeneron Sole Inventions.” The Parties agree that nothing in this Agreement, and no use by a Party of the other Party’s Intellectual Property pursuant to this Agreement, shall vest in a Party any right, title or interest in or to the other Party’s Intellectual Property, other than the license rights expressly granted hereunder.
Ownership of Newly Created Intellectual Property. Inventorship of Intellectual Property invented through the performance of activities under this Agreement shall be determined in accordance with United States patent laws (regardless of where the applicable activities occurred) and ownership of such Intellectual Property shall follow inventorship. Notwithstanding the previous sentence, all right, title and interest in any [***] Regeneron Materials Improvements, [***] Intellia CRISPR-Cas IP, Intellia Materials Improvements, Regeneron Product Inventions, [***], in each case, shall be determined in accordance with the following terms and conditions:
Ownership of Newly Created Intellectual Property. (a) Subject to Section 12.1(e), each Party (and each Party's respective Affiliates) shall exclusively own all intellectual property (including, without limitation, Know-How, Patents and Patent Applications and copyrights) discovered, invented, authored or otherwise created in connection with the Collaboration solely by such Party, its Affiliates, employees, agents and consultants ("Sole Inventions"). Sole Inventions made solely by Sanofi, its Affiliates, employees, agents and consultants are referred to herein as "Sanofi Sole Inventions". Sole Inventions made solely by Regeneron, its Affiliates, employees, agents and consultants are referred to herein as "Regeneron Sole Inventions". The Parties agree that nothing in this Agreement, and no use by a Party of the other Party's Intellectual Property pursuant to this Agreement, shall vest in a Party any right, title or interest in or to the other Party's Intellectual Property, other than the license rights expressly granted hereunder. Any remuneration payable under applicable law to an inventor and costs associated with determining such remuneration shall be treated as Other Shared Expenses.
Ownership of Newly Created Intellectual Property. The determination of whether Know-How or other inventions are invented by a Party for the purpose of allocating proprietary rights therein, shall, for purposes of this Agreement, be made in accordance with U.S. patent law or other Applicable Law in the United States irrespective of where such conception, discovery, development, or making occurs. As between the Parties, each Party will own any and all inventions, improvements, works, and Know-How invented, discovered, conceived, created, or otherwise generated (including as necessary to establish authorship (in case of publication and other copyrightable work), inventorship (in case of inventions, whether patentable or not) or ownership), solely by or on behalf of such Party or its Affiliates (or its or their respective directors, officers, employees, or agents), in the course of performing activities under this Agreement, and any and all Patent Rights and other Intellectual Property Rights thereto, and the Parties shall jointly own an equal and undivided interest in all Joint IP, [***], Kiniksa shall [***].
Ownership of Newly Created Intellectual Property. Except as otherwise provided in an individual SOW, ownership of any Intellectual Property developed as part of a SOW shall be granted to CCNC to hold on behalf of the Alliance collectively.
Ownership of Newly Created Intellectual Property. Ownership of any Intellectual Property developed as part of a SOW shall be determined in the SOW giving rise to that Intellectual Property or an amendment thereto.
Ownership of Newly Created Intellectual Property. Any patentable or unpatentable discoveries, ideas, including methods, techniques, know-how, concepts, or products ("Invention"); or any works fixed in any medium of expression, including copyright and mask work rights ("Works of Authorship"); or any other intellectual property created by Telcordia during the course of the Services shall be the sole and exclusive property of Telcordia. Any Inventions, Works of Authorship or other intellectual property created jointly by Telcordia and NAPA during the course of the Services shall be the joint property of Telcordia and NAPA, each party having full licensing rights with no obligation of accounting to the other party.
Ownership of Newly Created Intellectual Property. (a) Notwithstanding Section 6.1 above, any Intellectual Property (i) created or developed at the direction, request or under the authority of the JSC or (ii) whose creation or development was funded, in whole or in part (or the cost of which has or will be shared) by both of the Parties, shall be jointly owned and treated as if jointly developed in accordance with Section 6.3(b) below. * Confidential portions omitted and filed separately with the Commission.
Ownership of Newly Created Intellectual Property. During the Term of this Agreement, each of ALMIRALL and FOREST shall keep the other Party fully informed with respect to any new intellectual property (including, without limitation, data, discoveries, technical information, Know-how, patents, patent applications, proprietary information, trade secrets and inventions) invented, discovered or generated by it or its Affiliates, agents or employees resulting from Development activities. All intellectual property (including, without limitation, data, discoveries, technical information, Know-how, patents, patent applications, proprietary information, trade secrets and inventions) directly relating to LAS 34273, Monotherapy Product(s) or Combination Product(s) and the Device resulting from Development activities during the Term of this Agreement shall be owned by ALMIRALL; provided that FOREST (and its Affiliates) shall be entitled to use such intellectual property (which shall be deemed included in the license granted to FOREST hereby) for the purposes of fulfilling its rights and obligations under this Agreement. ALMIRALL shall retain the right to use (by itself, its Affiliates and/or its licensees) any intellectual property of FOREST which may be used with LAS 34273, Monotherapy Product(s) and/or Combination Product(s), free of any charge. Any intellectual property invented by FOREST not exclusively related to any of LAS 34273, Monotherapy Product(s) or Combination Product(s), shall be owned by FOREST, provided also that ALMIRALL shall have a perpetual, worldwide (subject to FOREST rights under this Agreement) and royalty-free right to use by itself, its Affiliates and/or licensees in connection with any of LAS 34273, Monotherapy Product(s) or Combination Product(s). Intellectual property created jointly by ALMIRALL and FOREST will be treated in a manner consistent with the foregoing (i.e., it shall be owned by ALMIRALL subject to FOREST’s license hereunder and, in the event not exclusively related to LAS 34273 Monotherapy Product or Combination Product, FOREST may retain its joint ownership interest, subject to the perpetual, royalty-free license to ALMIRALL as described above). Any intellectual property related to the Device shall be owned by ALMIRALL.
